MoonLake Immunotherapeutics: Audience

MoonLake Immunotherapeutics is a clinical-stage biopharmaceutical company focused on developing innovative therapies for serious inflammatory diseases. Their lead product, Sonelokimab, targets specific interleukins to improve patient outcomes in conditions like psoriasis and psoriatic arthritis.